Medtronic Plc (MDT) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from Jul 31 2026 to Jul 25 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Medtronic Plc  (NYSE: MDT)


Medtronic Plc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Medtronic Plc's ROI in the first quarter of 2026?
Medtronic Plc achieved a return on average invested assets (ROI) of 6.49 % in its first quarter of 2026, which is below Medtronic Plc's average return on investment, which stands at 8.62%.

ROI has improved compared to 6.01% in the fourth quarter of 2026, due to net income growth.

Within the Healthcare sector 129 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 1513 to 1614.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jul 31 2026)
I. Quarter		 (Apr 24 2026)
IV. Quarter		 (Jan 23 2026)
III. Quarter		 (Oct 24 2025)
II. Quarter		 (Jul 25 2025)
I. Quarter
Y / Y Investment Change TTM 2.83 % 1.95 % 1.07 % 0.23 % -1.32 %
Y / Y Net Income Change TTM 12.37 % 3.11 % 27.8 % 105.93 % 347 %
Investment (TTM) in Millions 82,125 81,979 79,033 81,615 79,266
Return On Investment (TTM) 6.49 % 6.01 % 5.82 % 6.01 % 5.94 %
MDT's Overall Ranking # 1614 # 1513 # 1121 # 1057 #
Seq. Investment Change TTM 0.89 % 0.92 % 0.05 % 0.94 % 0.03 %
Seq. Net Income Change TTM 8.93 % 4.27 % -3.19 % 2.2 % -0.04 %
Net Income (TTM) in Millions 5,269 4,837 4,639 4,792 4,689

MDT Company Profile >> Back to MDT Roi Comparisons >> See Annual MDT Return On Investment



Return On Investment MDT's Ranking
Within: No.
Industry # 39
Sector # 130
Overall # 1614

Return On Investment Statistics
High Average Low
19.75 %
8.62 %
2.79 %
(July 26. 2006)   (Oct 26 2018)







Financial Statements
Medtronic Plc's I. Quarter Investments $ 82,125 Millions MDT's Balance sheet
Medtronic Plc's I. Quarter Income $ 1,479 Millions Quarterly MDT's Income Statement
MDT's Income by Division See MDT's Income by Division


MDT Annual Return On Investment (Apr 24 2026)
2026		 (Apr 25 2025)
2025		 (Apr 26 2024)
2024		 (Apr 28 2023)
2023		 (Apr 29 2022)
2022
Total Investments in Millions 81,979 79,033 78,883 81,371 77,875
Y / Y Investment Growth 3.73 % 0.19 % -3.06 % 4.49 % -8.11 %
Net Income in Millions 4,837 4,691 3,705 3,784 5,062
Y / Y Net Income Growth 3.11 % 26.61 % -2.09 % -25.25 % 39.45 %
Annual Return On Investment 5.9 % 5.94 % 4.7 % 4.65 % 6.5 %


Annual Roi Comment
In the fiscal year 2026 ROI deteriorated to 5.9 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MDT's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MDT's Competitors
Subscribers only: Roi for Medtronic Plc's Suppliers
Subscribers only: Return On Investment for MDT's Customers

Other Ratios
MDT's Roa MDT's Inventory Turnover Ratio MDT's Growth Rates MDT's Dividend Statistics
MDT's Profitability Ratios MDT's Asset Turnover Ratio MDT's Dividend Growth
MDT's Roe MDT's Valuation Ratios MDT's Financial Strength Ratios MDT's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 31 2026, within Healthcare Sector ROI
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %

Date modified: 2026-09-26T07:25:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.